АНАЛІЗ ТРАДИЦІЙНИХ ТА НОВИХ ШТАМІВ ЛАКТОБАКТЕРІЙ: ФУНКЦІОНАЛЬНІ ВЛАСТИВОСТІ ТА КЛІНІЧНИЙ ПОТЕНЦІАЛ
Ключові слова:
Lactobacillus, probiotic strains, microbiome, comparative analysis, clinical applicationАнотація
The study analyzes traditional and novel strains of Lactobacillus, Lacticaseibacillus, Lactiplantibacillus, Limosilactobacillus from the perspective of their functional properties and clinical potential. The work focuses on the biochemical and probiotic profiles of various strains and their potential application in therapy and microbiota modulation.
Посилання
Functional analysis of Lactobacillus species in the human microbiome. / S. Lebeer et al. Trends in Microbiology. 2008. Vol. 16, no. 12. P. 538–546. URL: https://doi.org/10.1016/j.tim.2008.09.008.
Impact of probiotics on colonizing microbiota. / M.E. Sanders Journal of Clinical Gastroenterology. 2011. Vol. 45, Suppl. S. P. S115–S119. URL: https://doi.org/10.1097/MCG.0b013e318227414a.
Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. / A.L. Servin FEMS Microbiology Reviews. 2004. Vol. 28, no. 4. P. 405–440. URL: https://doi.org/10.1016/j.femsre.2004.01.003.
A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. / J. Zheng et al. International Journal of Systematic and Evolutionary Microbiology. 2020. Vol. 70, no. 4. P. 2782–2858. URL: https://doi.org/10.1099/ijsem.0.004107.
Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. / C. Hill et al. Nature Reviews Gastroenterology & Hepatology. 2014. Vol. 11, no. 8. P. 506–514. URL: https://doi.org/10.1038/nrgastro.2014.66.
Effects of Lactobacillus plantarum 299v on irritable bowel syndrome symptoms and intestinal microbiota: A randomized placebo-controlled trial. / C.L. Karlsson et al. Scandinavian Journal of Gastroenterology. 2012. Vol. 47, no. 9. P. 1046–1054. URL: https://doi.org/10.3109/00365521.2012.699112.
Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. / J.K. Spinler et al. Applied and Environmental Microbiology. 2014. Vol. 80, no. 2. P. 578–585. URL: https://doi.org/10.1128/AEM.01841-13.
Probiotics and immunity. / A.T. Borchers et al. Immunology and Allergy Clinics of North America. 2009. Vol. 29, no. 2. P. 247–268. URL: https://doi.org/10.1016/j.iac.2009.01.005.
Antagonistic action of Lactobacillus acidophilus toward intestinal pathogens. / S.E. Gilliland et al. Journal of Dairy Science. 1977. Vol. 60, no. 4. P. 604–610. URL: https://doi.org/10.3168/jds.S0022-0302(77)83893-3.
Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis: The results of the ProPAD trial. / L. Carucci et al. Pediatric Allergy and Immunology. 2022. Vol. 33, no. 8. e13836. URL: https://doi.org/10.1111/pai.13836.
Lactobacillus plantarum in gastrointestinal diseases: mechanisms and therapeutic potential. / Q.R. Ducarmon et al. Microbial Cell Factories. 2019. Vol. 18, no. 1. Article 97. URL: https://doi.org/10.1186/s12934-019-1144-8.
Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. / F. Savino et al. Pediatrics. 2010. Vol. 126, no. 3. P. e526–e533. URL: https://doi.org/10.1542/peds.2010-0433.
Survivability of probiotics in simulated gastric and intestinal juices. / Y. Huang et al. Food Research International. 2021. Vol. 141. Article 110142. URL: https://doi.org/10.1016/j.foodres.2021.110142.
Lactobacillus crispatus inhibits Gardnerella vaginalis and Prevotella bivia in a triple-species biofilm. / S. Borges et al. Anaerobe. 2014. Vol. 30. P. 132–135. URL: https://doi.org/10.1016/j.anaerobe.2014.09.002.
Engineering Lactobacillus for delivery of therapeutic and prophylactic molecules. / P.A. Bron et al. Trends in Biotechnology. 2012. Vol. 30, no. 10. P. 514–522. URL: https://doi.org/10.1016/j.tibtech.2012.06.005.
Connecting the dots: Translating the vaginal microbiome into a drug. / L.A. Lagenaur et al. Journal of Infectious Diseases. 2021. Vol. 224, Suppl. 3. P. S152–S158. URL: https://doi.org/10.1093/infdis/jiab455.
